Status:

UNKNOWN

Effects of Short- Term Intermittent Fasting Aerobic and Anaerobic Capacity

Lead Sponsor:

Faculdade de Motricidade Humana

Conditions:

Healthy Males

Men

Eligibility:

MALE

18-30 years

Phase:

NA

Brief Summary

The therapeutic use of caloric restriction and intermittent fasting (IF) protocols improves life span and health related quality of life. The effects of fasting protocols on athletic performance and t...

Detailed Description

This 3-year project will include two groups of participants: 1) young men accustomed to resistance training (study #1) and 2) young men accustomed to endurance training (study #2). Inclusion will be l...

Eligibility Criteria

Inclusion

  • Inclusion will be limited to young, healthy men with aged 20- 30 years. All participants will exhibit \> 3 years of continued experience and current participation in strength and power sports/training (training frequency of at least 3 times/wk). As importantly, the following criteria will also be determinant for inclusion: 1) bench press one-repetition maximum/bodyweight ratio \> 1.26 (i.e. above the 80 percentile for 20 to 29-year-old males) (ACSM 2013) and 2) leg press one-repetition maximum /bodyweight ratio \> 2.08 (i.e. above the 80 percentile for 20 to 29-year-old males) (ACSM 2013). Finally, for inclusion, all participants will have to follow the nutritional and training recommendations at pre-testing time point.
  • For study 2, as for study 1, Inclusion will be limited to young, healthy men with aged 20- 30 yrs. All participants will exhibit \> 3 yrs of continued experience and current participation in endurance based sports/training (training frequency of at least 3 times/wk). We will only include participants with VO2peak values \> 49 mL.kg-1.min-1(i.e. above the 80 percentile for 20 to 29-year-old males) (ACSM 2013). Finally, for inclusion, all participants will have to follow the nutritional and training recommendations at pre-testing time point.

Exclusion

  • All participants who do not meet the inclusion criteria mentioned above.

Key Trial Info

Start Date :

May 22 2018

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 5 2023

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT04756635

Start Date

May 22 2018

End Date

February 5 2023

Last Update

July 26 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Joana Correia

Lisbon, Portugal, 1499-002